期刊文献+

益气除痰法与化疗联合治疗中晚期非小细胞肺癌的临床观察 被引量:3

Clinical Observation Qi Expectorant Combination With Chemotherapy in Treatment of Middle-late Stage Non-small Cell Lung Cancer
下载PDF
导出
摘要 目的观察益气除痰法与化疗联合治疗中晚期非小细胞肺癌的临床效果。方法选取我院收治的中晚期肺小细胞肺癌患者54例,将其随机分为观察组(益气除痰法联合化疗)与对照组(单独给予化疗),对比两组患者治疗效果。结果观察组总有效率高于对照组,且观察组治疗前,卡氏评分与对照组比较无统计学意义(P>0.05);治疗后,观察组卡氏评分优于对照组,有统计学意义(P<0.05)。结论益气除痰法与化疗联合治疗中晚期非小细胞肺癌的临床效果显著。 Objective To observe the Qi expectorant method in combination with chemotherapy in treatment of advanced non-small cell lung cancer clinical effect. Methods 54 patients admitted to our hospital with advanced lung cancer patients with small cell lung were randomly divided into two groups (Qi expectorant method combined with chemotherapy) and control group (administered with chemotherapy alone), compared to the treatment groups of patients. Results The total efficiency higher than before and the observation group, Karnofsky and control group was not statistically significant (P〉0.05), after treatment, the observation group than the control group's score card, there statistically significant (P〈0.05). Conclusion Qi expectorant method in combination with chemotherapy in treatment Of advanced non-small cell lung cancer effect is remarkable.
作者 纪国义
出处 《中国继续医学教育》 2015年第25期210-212,共3页 China Continuing Medical Education
关键词 益气除痰法 化疗 中晚期 非小细胞肺癌 Qi expectorant method, Chemotherapy, Middle-late stage,Non-small cell lung cancer
  • 相关文献

参考文献4

二级参考文献31

  • 1Zhao T , Lu LQ, Qin ZQ, et al. Early changes of CY- FRA21-1 after chemotherapy are used for assessment of therapeutic effect of non-small-cell lung cancer at progres-sive stage. Yi Xue Yan Jiu Za Zhi 2012; 41(8): 286-288.
  • 2Lu H, Liu SM. Treatment of non-small-cell lung cancer and patient's quality of life. Guangdong Yi Xue 2010; 18 (16): 158-159.
  • 3Liu ZC. Advances of integrated Chinese-western treat- ment of late non-small-cell lung cancer. Zhong Yi Yao Lin Chuang Za Zhi 2012; 22(4): 256-257.
  • 4China Anticancer Association. Newly compiled standards for diagnosis and treatment of commonly-seen malignant tumors. Beijing: China Union Medical University Press, 1999: 7736.
  • 5Zeng XY. Guiding principles of clinical researches of new chinese drugs. Beijing: China Medical Science and Tech- nology Press, 20(2): 125-129.
  • 6He WF. Clinical observation on 30 cases of late non-small- cell lung cancer treated by integrated Chinese-western thera- py. ZhongYiYao Dao Bao 2011; 17(6): 221-222.
  • 7Wang Y, Lin KH, Long D, et al. Clinical observation on 30 cases of late non-small-cell lung cancer treated by Jinfei decoction combined with chemotherapy containing plati- num. Hebei ZhongYi 2010; 32(5): 186-188.
  • 8Marcus MT, Schmitz J, Moeller G. Mindfillness-based stress reduction in therapeutic community treatment: a stage 1 trial. Am J Drug Alcohol Ab 2009; 12(2): 366-367.
  • 9Disselhoff BC, Buskens E, Kelder JC. Randomized com- parison of costs and cost- effectiveness of cryostripping and endovenous laser ablation for varicose veins: 2-year re- suits. Eur J Vasc Endovasc 2009; 18(3): 254-255.
  • 10Li LN, Liu WS, Xu K, et al. Effect of TCM syndrome dif- ferentiation treatment combined with chemotherapy on prognosis factors of middle-late non-small-cell lung can- cer. Zhong Guo Zhong Xi Yi Jie He Za Zhi 2003; 23(8): 575-579.

共引文献30

同被引文献50

引证文献3

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部